Journal Information
Vol. 43. Issue 9.
Pages 523-524 (January 2007)
Vol. 43. Issue 9.
Pages 523-524 (January 2007)
Letters to the Editor
Full text access
Rebuttal of: “Can Home Prophylaxis for Venous Thromboembolism Reduce Mortality Rates in Patients With Chronic Obstructive Pulmonary Disease?”
Visits
3438
This item has received
Article information
Full text is only aviable in PDF
REFERENCES
[1]
M Modesto-Alapont, D Nauffal-Manzur, E Ansotegui-Barrera, R Menéndez-Villanueva, A Ballesta, R Touza, et al.
¿Puede reducir la mortalidad de los pacientes con EPOC la profilaxis domiciliaria de la enfermedad tromboembólica venosa?.
Arch Bronconeumol, 42 (2006), pp. 130-134
[2]
MM Samama, AT Cohen, JY Darmon, L Desjardins, A Eldor, C Janbon, et al.
A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.
N Engl J Med, 341 (1999), pp. 793-800
[3]
B Lindblad, NH Sternby, D Bergqvist.
Incidence of venous thromboembolism verified by necropsy over 30 years.
BMJ, 302 (1991), pp. 709-711
[4]
PA McKelvie.
Autopsy evidence of pulmonary thromboembolism.
Med J Aust, 160 (1994), pp. 127-128
[5]
J Suchankova, M Mata, J Cortijo, EJ Morcillo.
Effects of bemiparin on airway responses to antigen in sensitized Brown-Norway rats.
Eur J Pharmacol, 507 (2005), pp. 261-271
[6]
European Medicines Agency (EMEA). Committee for Medicinal Products for Human Use (CHMP). Guideline on clinical investigation of medicinal products for the prophylaxis of venous thromboembolic risk in non-surgical patients. Doc. Ref. CPMP/EWP/6235/04. London: EMEA; June 2006
Copyright © 2007. Sociedad Española de Neumología y Cirugía Torácica (SEPAR)